Elevated Intestinal Inflammation in Preterm Infants With Signs and Symptoms of Gastroesophageal Reflux Disease. Issue 3 (July 2021)

• Record Type: Journal Article
• Authors: Shelly, Colleen E.; Filatava, Evgenia J.; Thai, Julie; Pados, Britt F.; Rostas, Sara E.; Yamamoto, Hidemi; Fichorova, Raina; Gregory, Katherine E.
• Is Part Of: Biological research for nursing. Volume 23:Issue 3(2021)
• Page Start: 524
• Page End: 532
• Publication Date: 2021-07
• Subjects: fecal calprotectin (fCal) -- urinary intestinal fatty-acid binding protein (I-FABP) -- inflammatory marker -- GERD -- neonatal -- preterm; Clinical biochemistry -- Periodicals; Physiology, Pathological -- Periodicals; Nursing -- Periodicals; Nursing -- Research -- Periodicals; 610.73
• DOI: 10.1177/1099800420987888
• Languages: English
• ISSNs: 1099-8004

Abstract

Objectives: Reflux is common in infancy; however, persistent signs and symptoms of gastrointestinal distress are often attributed to gastroesophageal reflux disease (GERD). In this pilot study, we aimed to characterize associations between signs and symptoms of suspected GERD and noninvasive markers of intestinal inflammation in preterm infants. Methods: We reviewed Electronic Medical Record (EMR) data to identify clinical signs and symptoms among case patients (n = 16). Controls (n = 16) were matched on gestational age. Univariate and multivariate regression analyses were used to compare fecal calprotectin and urinary intestinal fatty acid binding protein (I-FABP) levels between cases and controls. Results: We found no differences in baseline characteristics between cases and controls. In the multivariate regression analysis controlling for the proportion of mother's milk, cases had higher fecal calprotectin levels than controls, with no differences in I-FABP levels between cases and controls. Conclusion: Our findings suggest that preterm infants with signs and symptoms of GERD have higher levels of intestinal inflammation as indicated by fecal calprotectin compared to their controls. Further studies are needed to evaluate the role of intestinal inflammation in signs and symptoms of gastrointestinal distress and whether fecal calprotectin might have predictive value in diagnosing GERD.